Come up with a name for your new list and we'll add to it:
Aravasc raised a round of funding on July 10, 2006. Investors include
National Science Foundation.
Aravasc is a company that received a SBIR Phase I grant for a project entitled: Drug Eluting Stents to Treat Obstructed Tracheo-Bronchial Lumen Due to Lung Cancer. Their research project will demonstr…